Showing results (511-520 of 550) with videos related to

Sort By:
Pageof 55
European Heart Journal|May 17, 2024
Incident heart failure in chronic kidney disease: proteomics informs biology and risk stratificationRuth F Dubin, Rajat Deo, Yue Ren, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 29, 2020
Biomarkers of Exposure among Adult Smokeless Tobacco Users in the Population Assessment of Tobacco and Health Study (Wave 1, 2013-2014)Yu-Ching Cheng, Carolyn M Reyes-Guzman, Carol H Christensen, et al.
Kidney International|February 5, 2022
Trans-ethnic genome-wide association study of blood metabolites in the Chronic Renal Insufficiency Cohort (CRIC) studyEugene P Rhee, Aditya Surapaneni, Zihe Zheng, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 8, 2021
Urinary Cotinine and Cotinine + Trans-3'-Hydroxycotinine (TNE-2) Cut-points for Distinguishing Tobacco Use from Nonuse in the United States: PATH Study (2013-2014)Kathryn C Edwards, Tasmia Naz, Cassandra A Stanton, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 21, 2023
Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH StudyKathryn C Edwards, Asia Khan, Eva Sharma, et al.
BMC Nephrology|June 2, 2025
Using vascular biomarkers to assess heart failure event risk in hospitalized patients with and without AKIAudrey A Shi, Anna Simone Andrawis, Aditya Biswas, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|December 13, 2021
Serum Concentrations of Cotinine and Trans-3'-Hydroxycotinine in US Adults: Results From Wave 1 (2013-2014) of the Population Assessment of Tobacco and Health StudyConnie S Sosnoff, Kevin Caron, J Ricky Akins, et al.
Contemporary Clinical Trials|December 12, 2023
The design and baseline characteristics for the HOPE Consortium Trial to reduce pain and opioid use in hemodialysisLaura M Dember, Jesse Y Hsu, Leah Bernardo, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 14, 2025
Chronic Pain Locations, Characteristics, and Associations With Other Symptoms in Adults Receiving Maintenance Hemodialysis: Findings From the HOPE Consortium TrialMichael J Fischer, Jesse Y Hsu, Joanna Walsh, et al.
International Journal of Environmental Research and Public Health|February 15, 2022
Changes in Biomarkers of Tobacco Exposure among Cigarette Smokers Transitioning to ENDS Use: The Population Assessment of Tobacco and Health Study, 2013-2015Gabriella M Anic, Brian L Rostron, Hoda T Hammad, et al.
Pageof 55